Climb Bio News and Activities

Climb Bio is a company listed under the stock ticker CLYM (US).

Acquisition, funding and merger involving Climb Bio.

• Eliem Therapeutics will change its company name to Climb Bio on Oct 3, 2024. (posted on October 3 2024).

View the org chart displaying its 22 main executives

Most searched biographies at Climb Bio

• Aoife Brennan, President, Chief Executive Officer and Director
• Judith Dunn, Director
• Andrew Levin, Director

Popular executive movements at Climb Bio

• Ashley Jones has joined the company as Senior Vice President, People and Workforce Strategy  (posted on October 21 2025).
• Susan Altschuller has joined the company as Chief Financial Officer  (posted on October 1 2025).

Create your alert
to follow the executive moves at Climb Bio.

Climb Bio has 2,415 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).
• Boundless Bio will change its company name to Serapha Bio on Dec 31, 2026. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Climb Bio

• Climb Bio Announces Pipeline Progress and Strategic Priorities for 2026 | Climb Bio
• Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Climb Bio
• Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates | Climb Bio
• Climb Bio to Present at Upcoming Investor Conferences | Climb Bio
• Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy | Climb Bio
• Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025 | Climb Bio
• Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer | Climb Bio
• Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN | Climb Bio
• Press Releases | Climb Bio
• Press Releases | Climb Bio
• View more press releases Close

Social media about Climb Bio

• Climb Bio on Wikipedia, Google News & Yahoo Finance
• Climb Bio on LinkedIn, X (Twitter) & YouTube